Dimming the corona: studying SARS-coronavirus-2 at reduced biocontainment level using replicons and virus-like particles

mBio. 2024 Dec 11;15(12):e0336823. doi: 10.1128/mbio.03368-23. Epub 2024 Nov 12.

Abstract

The coronavirus-induced disease 19 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections, has had a devastating impact on millions of lives globally, with severe mortality rates and catastrophic social implications. Developing tools for effective vaccine strategies and platforms is essential for controlling and preventing the recurrence of such pandemics. Moreover, molecular virology tools that facilitate the study of viral pathogens, impact of viral mutations, and interactions with various host proteins are essential. Viral replicon- and virus-like particle (VLP)-based systems are excellent examples of such tools. This review outlines the importance, advantages, and disadvantages of both the replicon- and VLP-based systems that have been developed for SARS-CoV-2 and have helped the scientific community in dimming the intensity of the COVID-19 pandemic.

Keywords: COVID-19; SARS-CoV-2; coronavirus; drug discovery; replicon; vaccines; virus-like particles.

Publication types

  • Review

MeSH terms

  • COVID-19 Vaccines / immunology
  • COVID-19* / prevention & control
  • COVID-19* / virology
  • Containment of Biohazards
  • Humans
  • Replicon*
  • SARS-CoV-2* / genetics
  • Vaccines, Virus-Like Particle / immunology

Substances

  • Vaccines, Virus-Like Particle
  • COVID-19 Vaccines